TENT4B rs138572890: Genetics of Sleep Variation
The rs138572890 single-nucleotide polymorphism is a regulatory variant located in the 3' untranslated region of the TENT4B gene (formerly known as PAPD5). Genome-wide analysis has identified preliminary statistical links between this variant and complex patterns of composite sleep health. However, direct scientific evidence remains limited, and the variant represents a subtle statistical marker rather than a diagnostic determinant of sleep disorders.
What each genotype means
Typical sleep health profile
This genotype represents the most common form of the TENT4B (PAPD5) variant. Research indicates that this variant is associated with composite sleep health scores, specifically those related to sleep duration and insomnia symptoms, though the evidence remains limited. This finding is based on statistical associations in large population studies and does not indicate a medical condition.
This is the major allele genotype, carried by the vast majority of individuals in European populations.
Associated with sleep health variation
This genotype involves the insertion of the CTTTA sequence. It has been identified in genome-wide association studies as being linked to composite sleep health traits, potentially influencing pathways related to RNA surveillance and glucose transport. Because this association is based on limited evidence, it should be viewed as a statistical observation rather than a diagnostic indicator of sleep quality.
This heterozygous genotype is relatively rare, with the minor allele frequency observed at approximately 0.01 to 0.03 in European populations.
Rare sleep health variant
This homozygous genotype for the insertion allele is very uncommon. While the CTTTA allele is associated with variations in composite sleep health scores in research settings, the clinical significance of carrying two copies of this variant is not well-established. Further research is required to understand how this specific genotype influences sleep patterns at an individual level.
This genotype is extremely rare, occurring at a very low frequency in the general population consistent with the low minor allele frequency of the variant.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism designated rs138572890 is mapped to the human TENT4B gene, historically cataloged in scientific literature as PAPD5. Located within the 3' untranslated region (3' UTR) of the transcript, rs138572890 does not alter the amino acid sequence of the resulting protein. Instead, variants residing in untranslated regulatory regions frequently influence post-transcriptional mechanisms, such as messenger RNA stability, translation efficiency, or microRNA binding dynamics. Modern public sequence repositories like dbSNP and Ensembl document rs138572890 as a low-frequency biallelic variation. Because it falls outside protein-coding exons, researchers evaluate its functional consequences through expression quantitative trait loci (eQTL) modeling and regulatory genomics rather than structural protein disruption. Understanding its placement helps geneticists distinguish between causative molecular lesions and subtle regulatory modifications across the human genome.
Biological Function of the TENT4B Gene
The TENT4B gene encodes terminal nucleotidyltransferase 4B, a non-canonical poly(A) polymerase that plays an essential role in post-transcriptional gene regulation. Unlike classical polyadenylation enzymes that synthesize purely adenosine-rich tails, TENT4B catalyzes mixed tailing by intermittently incorporating non-canonical nucleotides such as guanosine or cytidine into messenger RNA poly(A) tails. This mixed tailing prevents swift exonucleolytic deadenylation, thereby shielding mRNA molecules from premature degradation and extending their cellular functional lifespan. TENT4B is also deeply involved in non-coding RNA surveillance, telomerase RNA maturation, and broader cellular response pathways. Because cellular mRNA turnover directly regulates rhythmic transcript abundance in human tissues, alterations in nucleotidyltransferase activity have generated significant scientific interest regarding how post-transcriptional fine-tuning might interface with human behavioral endophenotypes.
Sleep Research and Evidence Strength
Genome-wide association studies (GWAS) indexed in public repositories have mapped rs138572890 to traits involving composite sleep health metrics and variations in sleep architecture. Researchers utilize multi-component sleep scores—combining parameters like sleep duration, chronotype preference, daytime sleepiness, and insomnia symptoms—to capture holistic sleep quality across large biobanks. Within these large-scale association screens, rs138572890 demonstrated statistical correlation with altered composite sleep scores. Nevertheless, the existing evidence base is strictly characterized as limited. The observed effect sizes are modest, a hallmark of complex behavioral traits influenced by hundreds of polygenic loci. Crucially, statistical correlation within observational epidemiological cohorts does not establish direct molecular causality, and experimental functional validation in cellular or animal models remains to be performed.
Population Distribution and Ancestry Patterns
Data aggregated from global sequencing initiatives, including the Genome Aggregation Database (gnomAD) and European biobanks, reveal that rs138572890 is a low-frequency genetic variant. Across individuals of European ancestry, the minor allele frequency typically hovers between 0.01 and 0.03 (1% to 3%). In many non-European populations, the minor allele is found at very low frequencies or has not been reliably captured due to limited sampling density. Consequently, the statistical associations described in current sleep studies reflect predominantly European discovery cohorts and cannot be assumed to generalize across diverse global ancestries. Ongoing sequencing efforts in more genetically diverse cohorts will be necessary to determine the universal relevance and allele frequency of rs138572890 worldwide.
Practical Implications and Clinical Perspective
Direct-to-consumer genetic panels frequently report variants like rs138572890 to offer insight into behavioral predispositions, but consumers should interpret these findings with care. A non-major genotype at rs138572890 does not mean an individual is destined to experience insomnia, altered sleep timing, or chronic sleep deprivation. Sleep health is overwhelmingly driven by environmental factors, lifestyle choices, light exposure, stress levels, and underlying medical conditions. This variant has no sanctioned diagnostic utility and is not utilized in clinical sleep medicine. Individuals struggling with unrefreshing sleep, daytime exhaustion, or chronic sleep disturbances should focus on evidence-based sleep hygiene interventions and consult a board-certified physician or sleep specialist rather than relying on single-gene association markers.
How common is this variant?
The minor allele for rs138572890 is observed at a low frequency of approximately 1% to 3% across European ancestry populations, with sparse and uncharacterized representation across other global ancestral groups.
Frequently asked questions
Can rs138572890 diagnose a sleep disorder?
No, rs138572890 is not a diagnostic marker for insomnia, sleep apnea, or any other medical sleep disorder. It is merely a statistical association identified in large epidemiological surveys with limited evidentiary confirmation. Clinical sleep diagnoses require comprehensive medical evaluations and physiological assessments.
How does TENT4B affect human biology?
The TENT4B gene encodes a nucleotidyltransferase enzyme that adds mixed chemical tails to messenger RNA molecules. This biochemical activity shields RNA transcripts from rapid cellular degradation, thereby regulating how long proteins are produced within tissues throughout the body.
Why is the scientific evidence for this variant considered limited?
While large genome-wide association studies identified a statistical correlation between rs138572890 and sleep patterns, the findings have not been independently replicated across large, diverse global cohorts. Furthermore, mechanistic laboratory studies directly demonstrating how this specific non-coding change affects sleep biology have not yet been completed.
What steps should I take if my genetic test shows this variant?
No medical intervention or lifestyle change is recommended based solely on rs138572890. If you experience fatigue, daytime sleepiness, or persistent sleep difficulties, you should discuss these symptoms with a qualified healthcare provider or sleep specialist.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs138572890?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29